EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment

Dong Hyun Park, Sang Uk Lee, Jin Seok Yu, Jun Seop Lee, Hye Jung Kwon

Kosin Medical Journal · 2012

DOI: 10.7180/kmj.2012.27.2.111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kosin Medical Journal, 2012. Verfasst von Dong Hyun Park und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The combination therapy with peginterferon and ribavirin has been used to treat chronic hepatitis C for several years in Korea but there is a few report about the results of the treatment. We evaluated safety and efficacy of the combination therapy with Peg-interferon and ribavirin and analyzed factors that may affect treatment.

Methods

Total 72 untreated chronic hepatitis C patients were administered pegylated interferon alfa-2a (180µg/week) or alfa-2b (1.5µg/kg/week) and ribavirin (800 mg/day in genotype 2, 1000-1200 mg/day in genotype 1). Duration of the treatment was 24 weeks in genotype 2 and 48 weeks in genotype 1. Response of the treatment was evaluated by rapid virologic response (RVR), early virologic response (EVR), end treatment virologic response (ETR), sustained virologic response (SVR) and adverse event.

Results

The RVR, EVR, ETR, SVR were 61.8%, 82.5%, 88.9% and 80.5% retrospectively. The SVR of genotype 1 was 63.4% and non-genotype 1 was 96.7%. Genotype (Odds ratio: 14.92) was an independent predictor of the SVR. Leukocytopenia, flu-like symptoms, itching, rash and anemia were common adverse events of the combination therapy and if then we reduced dose and there was one case of cessation.

Conclusions

The combination therapy with Peg-interferon and ribavirin shows efficacy to the Korean patients with chronic hepatitis C as an initial treatment. Genotypes 2 and 3 were more likely to have a sustained virologic response.

Zitieren

APA

Park, D. H., Lee, S. U., Yu, J. S., Lee, J. S., & Kwon, H. J. (2012). The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment. Kosin Medical Journal. https://doi.org/10.7180/kmj.2012.27.2.111

Vancouver

Park DH, Lee SU, Yu JS, Lee JS, Kwon HJ. The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment. Kosin Medical Journal. 2012. doi:10.7180/kmj.2012.27.2.111

BibTeX
@article{Park2012,
  author = {Park, Dong Hyun and Lee, Sang Uk and Yu, Jin Seok and Lee, Jun Seop and Kwon, Hye Jung},
  title = {The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment},
  journal = {Kosin Medical Journal},
  year = {2012},
  doi = {10.7180/kmj.2012.27.2.111}
}
Kostenlos starten →